Practical approach on frail older patients attended for acute heart failure by Martín Sánchez, Fj et al.
International Journal of Cardiology 222 (2016) 62–71
Contents lists available at ScienceDirect
International Journal of Cardiology
j ourna l homepage: www.e lsev ie r .com/ locate / i j ca rdReviewPractical approach on frail older patients attended for acute heart failureFrancisco J. Martín-Sánchez a,h,⁎, Michael Christ b, Òscar Miró c,u, W. Frank Peacock d, John J. McMurray e,
Héctor Bueno f,g,h, Alan S. Maisel i, Louise Cullen j,k,l, Martin R. Cowie m, Salvatore Di Somma n, Elke Platz o,
Josep Masip p,v, Uwe Zeymer q, Christiaan Vrints r, Susanna Price s, Christian Mueller t,w
a Emergency Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), Spain
b Department of Emergency and Critical Care Medicine, Klinikum Nürnberg, Germany
c Emergency Department, Hospital Clínic, Barcelona, Catalonia, Spain
d Emergency Medicine, Baylor College of Medicine, Houston, TX, United States
e British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom
f Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
g Instituto de Investigación i+12 y Servicio de Cardiología, Hospital Universitario 12 de Octubre, Madrid, Spain
h Universidad Complutense de Madrid, Madrid, Spain
i Coronary Care Unit and Heart Failure Program, Veteran Affairs (VA) San Diego, United States
j Department of Emergency Medicine, Royal Brisbane and Women's Hospital, Brisbane, Australia
k School of Public Health, Queensland University of Technology, Brisbane, Australia
l School of Medicine, The University of Queensland, Brisbane, Australia
m Cardiology Department, Imperial College London (Royal Brompton Hospital), London, England, United Kingdom
n Emergency Medicine, Department of Medical-Surgery Sciences and Translational Medicine, Sant'Andrea Hospital, University La Sapienza, Rome, Italy
o Department of Emergency Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, USA
p ICU Department, Consorci Sanitari Integral, University of Barcelona, Barcelona, Spain
q Klinikum Ludwigshafen und Institut für Herzinfarktforschung Ludwigshafen, Ludwigshafen, Germany
r Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
s Royal Brompton and Harefield National Health Service Foundation Trust, United Kingdom
t Department of Cardiology, University Hospital Basel, Basel, Switzerland
u Institut de Recerca Biomàdica August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain
v Cardiology Department, Hospital Sanitas CIMA, Barcelona, Spain
w Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, Basel, Switzerland⁎ Corresponding author at: Emergency Department
Profesor Martín Lagos s/n, 28040 Madrid, Spain.
E-mail address: fjjms@hotmail.com (F.J. Martín-Sánch
http://dx.doi.org/10.1016/j.ijcard.2016.07.151
0167-5273/© 2016 Elsevier Ireland Ltd. All rights reserveda b s t r a c ta r t i c l e i n f oArticle history:
Received 17 May 2016
Accepted 15 July 2016
Available online 18 July 2016Acute heart failure (AHF) is amulti-organ dysfunction syndrome. In addition to known cardiac dysfunction, non-
cardiac comorbidity, frailty and disability are independent risk factors ofmortality,morbidity, cognitive and func-
tional decline, and risk of institutionalization. Frailty, a treatable and potential reversible syndrome very common
in older patients with AHF, increases the risk of disability and other adverse health outcomes. This position paper
highlights the need to identify frailty in order to improve prognosis, the risk–benefits of invasive diagnostic and
therapeutic procedures, and the definition of older-person-centered and integrated care plans.
© 2016 Elsevier Ireland Ltd. All rights reserved.Keywords:
Frailty
Older
Acute heart failure1. Introduction
The proportion of people over the age of 65 years is dramatically ris-
ing worldwide. It has been estimated that more than 30% of Europeans
will be over this age in 2050. One consequence of longer life expectancy
is the increased use of health care services. Although greater age does
not necessarily imply poorer health, the heterogeneity of the intrinsic
capacity varies enormously as a function of age between individuals., Hospital Clínico San Carlos,
ez).
.Ultimately, the different levels of health in aging are better contemplat-
ed in terms of frailty, rather than years alive that are arbitrary and pre-
dominately centered on socio-demographic aspects [1].
Heart failure (HF) is a chronic disease. It has an incidence and prev-
alence that are highly age-dependent. Three out of 4 patients over the
age of 75 years suffer with HF [2]. Acute HF (AHF) is a multi-organ dys-
function syndrome that involves cardiac, renal, pulmonary, cerebral,
and hepatic injuries. It is one of the most frequent causes of visits to
emergency departments (ED) and hospitalization [3,4]. Older patients
with AHF require a more complex evaluation and have a worse short-
term prognosis across the spectrum of morbidity, cognitive and func-
tional decline, and the risk of institutionalization and mortality,
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are probably more related to comorbidities, frailty and disability than
with chronologic age [5].
The terms comorbidity, frailty and disability are associated with
aging, and although commonly used interchangeably, they are unique
entities with different prognoses and health care implications [7,8]
(Fig. 1).
Comorbidity describes a framework where one specific disease is the
primary focus, and the other distinct entities are comorbid conditions
modifying the course and the treatment of an individual with the index
disease [9]. In HF patients, the prevalence of comorbidity has increased
in the last 2 decades [10] and is associated with adverse events [11].
Disability is defined as difficulty or dependency in performing activ-
ities of daily living [7]. Functional disability is prevalent in HF [10], and
the level of functional dependence determines a poor prognosis in
older patients with AHF [12].
Frailty is clinically characterized by a reduction in physiological ca-
pacity not necessarily related to a specific disease process and typically
involves alterations in multiple systems [13]. Frailty may be reversible
or attenuated by interventions [13]. It is more frequent in patients
with comorbidity and chronic diseases [10], particularly HF, than in
the general population [14]. It is associatedwith higher risks of hospital-
ization, disability andmortality [15]. Approximately 50–70%of older pa-
tients admitted for AHF present with some degree of frailty [16–18].
This contributes to adverse short and long-term outcomes both in
those managed medically and in relation to interventional procedures
[18–19].
Therefore, evaluation of older patients with AHF requires more than
an assessment of pump failure alone [20–24]. The identification ofFig. 1. Practical approach to assess the vulnerabilfrailty and its degree is critical to improve prognosis and optimize the
risk–benefit relationship of invasive diagnostic and therapeutic proce-
dures. An evaluation of frailty is also necessary to accurately define
older-person-centered and integrated care plans whose main goal is
tomaintain or reverse the potential decline in physical and cognitive ca-
pacities (add life to your years and not years to your life).
This position paper highlights the need to recognize that frailty, as a
syndrome, is different from aging, comorbidity and disability. We will
review the definition and diagnosis of frailty andwill present a practical
evaluation andmanagement of it and other possible concurrent circum-
stances in older patients attended with AHF.
2. Definitions of frailty
2.1. Concept
Frailty is a dynamic and nonlinear process. It describes a state of vul-
nerability to stressors in terms of systems reserves and capacity of re-
sponse to stress situations (i.e., decompensation of AHF) in older
populations [13]. This conceptmay help to identify patients at increased
risk of disability and/or other adverse health outcomes (i.e. death, re-
duced physical performance, functional decline, hospitalization or insti-
tutionalization) [13,25].
2.2. Models of frailty
Twomain models have been used to conceptualize frailty. These are
based on different theoretical constructs: 1) a biologic syndromemodel
and 2) an accumulation of deficiencies model [26].ity in older patients with acute heart failure.
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This model, based on data from the Cardiovascular Health Study,
considers frailty as a biologic syndrome characterized by the presence
of 3 or more of 5 components: 1) exhaustion, 2) unintentional weight
loss, 3) impaired grip strength, 4) slowness, and 5) low physical activity
[27] (Table 1). Subsequently, some authors have proposed variations of
the original model by introducing new criteria (i.e. cognitive impair-
ment) or even reducing the number of components required (i.e. slow
gait speed, low physical activity and weight loss) [25,28].
2.2.2. Frailty index (FI)
This model, derived from the Canadian Study of Health and Aging, is
based on deficit accumulation; that is, a measure of the cumulative bur-
den of non-specified age-associated health deficits (i.e. diseases, impair-
ments in cognition, mood, mobility, or function) associated with poor
outcomes. The frailty index was originally comprised of 70 measures
and conceptualized frailty as a continuum. This model counts disabil-
ities and comorbidities and is able to quantitatively summarize vulner-
ability [29].
Numerous other frailty definitions have been developed, but have
largely been based on these two basic conceptual approaches [30].
3. Tools for identifying frailty in older patients with AHF
3.1. Screening of frailty in the emergency setting
Several screening tools for frailty, based on a multi-domain ap-
proach, have been proposed [31]. The tools most frequently studied
are the Identification of Seniors at Risk (ISAR) [32] and Triage Risk
Screening Tool (TRST) [33]. Both are validated for older patients attend-
ing in the emergency department (ED). These are self-reported (or
obtained by a nurse) questionnaires, take approximately 1 min to ad-
minister, and are composed of six items related to different domains.
The score ranges from 0 to 6 (0 = low risk, 6 = high risk). A score of
two or more is associated with a greater probability of presenting
short- and long-term adverse outcomes (hospital readmission, ED re-
visit, and functional decline and mortality) [ 32,33]. These tools have aTable 1
Fried criteria.
Original frailty phenotype
(as proposed by Fried et al. 2001)
Exhaustion How often in the last week did you feel this way? (a) I felt that
everything I did was an effort; (b) I could not get going
A moderate amount of the time (3–4 days) or most of the time =
rarely or none of the time (b1 day) or some or a little of the time
Weight loss In the last year, have you lost more than 5 kg unintentionally
(i.e., not due to dieting or exercise)? yes = 1, no = 0
Physical activity Minnesota Leisure Time Activity Questionnaire (past 2 weeks):
walking, chores (moderately strenuous), mowing the lawn, rakin
gardening, hiking, jogging, biking, exercise cycling, dancing, aerob
bowling, golf, singles tennis, doubles tennis, racquetball, calisthen
swimming. Deficit given to (adjusted by sex)
-Men: kcals/week b 383;
-Women: kcals/week b 270
Grip strength Average grip strength score in dominant hand (3 trials) using a JA
held dynamometer. Deficit given to (adjusted by sex and BMI qua
on CHS population by Fried et al.)
-Men: BMI ≤ 24 kg and strength b29 kg; BMI 24.1–26 kg and stre
men: BMI 26.1–28 kg and strength b 30 kg; BMI 24.1–26 kg and
strength b 30 kg; BMI N 28 kg and strength b32 kg
-Women: BMI ≤ 23 kg and strength b17 kg; BMI 23.1–26 kg and
strength b17.3 kg; men: BMI 26.1–29 kg and strength b 18 kg; BM
Walking time Walking speed score (15 ft. (5 m) test, usual pace, one trial)
Deficit given to (adjusted by sex and median height based on CHS
-Men: height ≤ 173 cm and speed ≤ 0.6531 m/s; height N 173 cm
-Women: height ≤ 159 cm and speed ≤ 0.6531 m/s; height N 159
5 items: 0 deficits: nonfrail; 1–2 deficits: prefrail; ≥3 deficits: frail.high sensitivity and relatively low specificity, although the predictive
capacity for adverse outcomes of the ISAR seems better than that of
the TRST [31]. Regarding the frailty syndrome, the ISAR has shown a
good predictive capacity in identifying frail older patients in the ED [34].
The ISAR is considered a useful screening tool for frailty in older pa-
tients presenting to the ED [34] (Table S1 in the supplementary materi-
al). Taking into account its limitations [35], the use of the ISAR alone is
inadequate and the cut-off of ≥2 may be useful to select older patients
most likely to benefit from geriatric assessment [34]. Some authors
have suggested a higher cut-off point, or that consideration as a contin-
uous variable, may facilitate more efficient use of care resources [31].
They suggest a cut-off of 3 as better in terms of discriminative capacity
for adverse outcomes [36].3.2. Diagnosis of frailty in inpatient units
Many tools have been developed to diagnose frailty in the older pop-
ulation with substantial differences in respect to their ability to predict
adverse outcomes [37]. Nonetheless, the reliability and validity of
these tools have rarely been evaluated [38]. The few studies in which
they were tested were epidemiological and their application in the
cardiovascular setting, and specifically in HF, is limited [39] (Table 2).
Indeed, the best tool to determine frailty for use in research and clinical
practice remains to be established [38]. Therefore, when selecting a
frailty assessment tool, one must consider where it was validated
(setting and population), the mode of administration in relation to
time-consumption and personnel, and the specialized equipment re-
quired [38].
Most studies in HF are based on tools derived from the frailty pheno-
type (Fried Scale) or from some of its domains (Physical Performance
Test) [40]. There is less evidence on accumulations of deficits instru-
ments (i.e. Frailty Index-Comprehensive Geriatric Assessment (FI-
CGA) or Tilburg Frailty Indicator (TFI)) in the cardiovascular setting
[39,41] (Table 2).
The Fried Scale requires 3 ormore criteria (exhaustion, unintentional
weight loss, impaired strength, slowness, and low physical activity) for
the diagnosis of physical frailty (Table 1) [27]. It is important to take intoSelf-reported deficit
Self-report of fatigue or felt unusually tired or
weak in the past month.
1;
(1–2 days) = 0
Self-report weight loss N5 kg unintentionally
in the past year.
g,
ics,
ics,
Self-report frequency and duration of
physical activities.
MAR hand
rtile based
Self-report of difficulty standing up from a chair.
ngth b 30 kg;
I N 29 and strength b 21 kg
Self-report of any difficulty for walking 100 m.
population by Fried et al.)
and speed ≤ 0.762 m/s
cm and speed ≤ 0.762 m/s
Table 2
Principal studies about frailty in older patients with acute heart failure.
Setting Items Score (cut-off) Administer Domains Subjects Outcomes
Emergency department
ISAR
Identification
Seniors at Risk
McClusker (1999)
6 0–6
(≥2 = frailty)
Self-reported Cognition, ADL, medications,
vision, recent hospitalization
Patients ≥65 years
discharged from ED
30-Day mortality
30-Day hospital readmission
30-Day functional decline
Inpatients unit
SPPB
Short Physical
Performance Battery
Volpato (2008,2011)
Chiarantini (2010)
3 0–12
(b5 = frailty)
Physical performance 5-m gait speed test
Chair rise test
Balance test
Patients ≥65 years
admitted for AHF
Length of stay
Incident disability
15-Month mortality
TFI
Tilburg Frailty Indicator
Uchmanowicz I (2015)
15 0–15
(≥5 = frailty)
Self-reported Physical (8), psychological
(4), social (3).
Patients ≥60 years
admitted for AHF
Self-care capabilities
Health-related quality of life
MPI
Multi prognostic index
Pilotto (2010)
63 0–1
(0.34–0.66 = moderate risk;
0.67–1 = high risk)
Data abstracted out of
CGA by geriatrician
Cognition, ADL, nutrition,
comorbidities, medications,
decubitus, social support
Patients ≥65 years
admitted for AHF
1-Month mortality
CGA Score
Rodriguez Pascual
(2012,2014)
5 0–10
(≤2: lower risk; 3–4;
5–6; ≥7: higher risk)
Data abstracted out of
CGA by geriatrician
Cognition, ADL, mobility,
comorbidity, medications
Patients ≥75 years
admitted for AHF
In-hospital mortality
2-Year mortality
IADL: instrumental activities of daily living.
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et al. in 2001may influence the results. In order to compare the different
studies available using the frailty phenotype,minimum requirements of
the measurements must be reported [42].
Several Physical Performance tests have been described, including the
Short Physical Performance Battery, gait or walking speed, timed-up-
and-go test, handgrip strength, and 4 or 6-minute walk test, each of
which may identify physical frailty or preclinical disability in the older
population [43].
The Short Physical Performance Battery (SPPB) encompasses slow-
ness, weakness, and balance. This test assesses lower extremity function
using three physical performance tests that include standing balance
(the ability to stand with the feet together in the side-by-side, semi-
tandem, and tandem positions), gait speed (time to walk 8 ft or
2.4m), and strength and endurance (time to rise froma chair and return
to the seated position 5 times). The total score ranges from 0 to 12, with
higher scores indicating better performance [44]. The SPPB predicts in-
cident activities of daily living disability, worsening mobility and death
in older community HF subjects [45] (Fig. 2).
Gait speed is a part of the SPPB, but as a single parameter it has been
associatedwith survival in older adults [46]. It is an important risk factor
for 1-yearmortality in anolder community populationwithHF [47]. The
5-mdistance is a good balance between thewalking speed achieved and
cardiopulmonary limitations [39].
Alternatively, the timed get-up-and-go test measures the time
needed to complete a series of functionally important tasks such as
standing up from a chair, walking a short distance, turning around,
returning to the chair, and sitting down again [48]. This test appears
to be a reliable and valid functional measurement in patients with HF
[49]. A gait speed b0.8 m/s and a timed-up-and-go test N10 s are
markers of possible frailty in community-dwelling older patients
[50]. In patients with lower limb conditions, the handgrip test may
be an alternative option [51].
The SPPB is easily applied, preferable to other performance tests
(i.e. 4-m walk test, 6-minute walk test, and handgrip strength) in
community-dwelling older patients with HF [45], and it is currently
considered the best instrument to characterize frailty in clinical trials
[52]. In older patients with HF, a total SPPB score ≤4 applied at hospital
admission is an independent predictor of the length of hospital stay
[53]. Further, its measurement at hospital discharge is an independent
predictor of 30-day mortality [54] and rehospitalization [55].Comprehensive Geriatric Assessment (CGA) is the instrument recom-
mended for the evaluation and care of frail older patients in clinical
practice [56]. This holistic evaluation is performedby amultidisciplinary
team that usually includes a geriatrician or other physicians knowledge-
able in the care of older adults, a nurse, social worker, pharmacist, and
an occupational or physical therapist. This team assesses comorbidity,
polypharmacy, and cognitive, functional, nutritional, and socio-
economic areas in order to develop treatment planning and follow-up.
The main limitations of the CGA include the need to have experts of di-
verse disciplines and enough time for the evaluation. The CGA has dem-
onstrated ability to predict in-hospital and long-term adverse outcomes
in older patients admitted with HF [57–60]. Major geriatric syndromes
(frailty, severe disability, cognitive decline, and depression) are associ-
ated with poor intra-hospital and 1-year results in older patients with
acute cardiac conditions [58]. The CGA is currently the gold standard
to detect frailty and should be usedwhenmaking complex decisions re-
garding invasive procedures. Because of the limitations mentioned
above, some authors have proposed a Brief Geriatric Assessment adapted
to non-geriatricians using a combination of screening scales that ap-
proach different domains of the patient [61] (Table 3).
Various instruments derived from CGA have been published (i.e. Mul-
tidimensional Prognostic Index [MPI], CGA score, and Edmonton Frail
Scale [EFS]) that have a high predictive value of adverse short-term re-
sults. The MPI predicts the 1-month mortality in patients aged 65 years
and older admitted with AHF [57]. The CGA score estimates the in-
hospital and 2-year mortality in older patients hospitalized for AHF
[59,60]. The EFS tool may be useful to identify frailty when considering
a surgical intervention in order to help with pre-operative optimization
[50].
With regard to the last-mentioned instrument derived from CGA,
EFS is a brief multidimensional tool that may be applied in older admit-
ted patients by non-geriatricians. It includes the domains of cognition,
mood, mobility, functional independence, drugs, social support, nutri-
tion, health attitudes, continence, medical disease load and quality of
life [62]. The examination takes less than 5 min and the maximum
score (total 17) represents the highest level of frailty [62]. The new ver-
sion of this scale, the Reported Edmonton Frail Scale (REFS), adapted
from the EFS, substitutes the get up and go test with self-reporting of
physical function before the current illness. The REFS is scored from 1
to 18 [63]. With respect to the need for major cardiac interventional
or surgical decisions in invasive cardiovascular procedures, recent
Fig. 2. Short Physical Performance Battery. *See the videos in the supplementary electronic material.
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the REFS to diagnose frailty, and therefore a geriatric assessment is rec-
ommended in these cases [64].Table 3
Brief geriatric assessment based on comprehensive geriatric assessment.
Domain Tool
Cognitive Montreal Cognitive Assessment (MOCA)
Depression 5-item Geriatric Depression Scale (5-GDS)
Functional Lawton index (LI) (8 instrumental activities of daily living)
Barthel index (BI) (8 basic activities of daily living
and 2 of mobility).
Nutrition Mini-Nutritional Status — Short Form (MNA–SF)
Serum albumin
Polypharmacy START and STOPP Criteria
Comorbidity Charlson Comorbidity Index
Hearing Whispering test
Visual Snellen test
Socio-economic Gijon's social–familial evaluation scale (SFES)4. Evaluation of frailty in older patients with AHF
In all older patients presenting with AHF, the level of frailty must be
determined through assessment and monitoring of physical and cogni-
tive status during acute management, during convalescence and, above
all, at the time of hospital discharge [50]. Some circumstances, such as
clinical presentation (i.e. delirium, falls or acute functional decline) or
the presence of some level of baseline functional dependence on the
basic activities of daily living, may be used to indicate possible frailty
[50]. Biomarkers are only able to capture single aspects of frailty and
are weakly associated with clinically meaningful outcomes [65]. In the
absence of universal recommendation as to how to detect vulnerable
older patients in clinical practice, we suggest a simplistic approach in
the ED and ward settings (Fig. 3).
4.1. Emergency setting
In the ED, where personnel and time resources are limited, we rec-
ommend to screen for frailty, particularly in patients with non-
67F.J. Martín-Sánchez et al. / International Journal of Cardiology 222 (2016) 62–71apparent disability discharged directly from the ED. We recommend
using ISAR as a continuous variable, with a cut point ≥2 for maximum
sensitivity and ≥3 for maximum discrimination, to provide an individu-
alized care plan that includes a CGA program.
4.2. Inpatient units
On inpatient units, we recommend that information about comor-
bidity (Charlson Comorbidity Index) (Table S2 in the supplementary
material) [66] and baseline functional status (Barthel Index) (Table S3
in the supplementary material) [67], be collected at admission to estab-
lish the grade of disability.
In older patients with established disability (moderate and severe
disability), measurement of physical frailty should be focused on basic
activities of daily living and mobility. The Barthel Index has shown a
greater sensitivity to change and may detect the onset of disability
earlier than other scores [8] (Table). Previous studies have shown that
severe baseline functional dependence (Barthel Index b 60 points)
in older patients attended with AHF is associated with an increase
in 30-day mortality [12], and its inclusion in the HF risk stratifica-
tion models (Bi-EFFECT) has improved the prediction of 30-day
mortality [68]. In this profile patient's information about other
domains (e.g., comorbidity, medications, cognitive, nutritional and so-
cial support) should be included since these variables influence short-
and long-term prognoses, and care planning decisions [58–60].
We recommend using instruments based on the frailty phenotype
(i.e. the Fried Scale) or physical performance (i.e. SPPB) to diagnoseFig. 3. Approach to assess the frailty in olphysical frailty in older patients with non-established disability (pre-dis-
abled or mild disability) [69]. The presence of frailty is associated with
in-hospital, as well as short and long-term outcomes [53–55]. As men-
tioned above, there is no single feasible, valid tool to diagnose frailty
in AHF inpatients and neither has the best time to perform these tests
been established. Multi-domain tools do not necessarily provide incre-
mental value above single-domain tools, and the ease of implementa-
tion may be an important factor for adoption. Taking into account the
acute phase of the heart failure condition, self-reported instruments
may be more appropriate at hospital admission, while objective perfor-
mance measures would be better suited at hospital discharge. Finally,
some authors have also suggested the addition of cognitive and nutri-
tional status to improve the diagnosis of frailty [13].
It is also important to monitor the cognitive and functional situation
during hospitalization since delirium and acute functional decline are
markers of frailty [50]. Delirium is the main manifestation of cognitive
frailty and frequently appears in hospitalized elderly patients with cog-
nitive impairment. Its presence in patients with decompensated HF has
been associated with 30-day mortality [70]. The Confusion Assessment
Method (CAM) is a good tool for the identification of delirium [71].
The CAM for the Intensive Care Unit (CAM-ICU) [72] has shown to
have a better capacity to diagnose delirium in older patients in the ED
[73]. It is recommended that cognitive status is evaluated, after ruling-
out delirium, at the time of the first visit, or failing that, on ward admis-
sion. Montreal Cognitive Assessment (MoCA) is the best method to
screen for cognitive impairment in patientswithHF [74,75] in both clin-
ical practice and trials [52].der patients with acute heart failure.
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The management of older patients with AHF should be based on
clinical guidelines taking into account that older patients, and particu-
larly frail older patients, have often been excluded from clinical trials
[76,77]. We recommend the measurement of the degree of frailty as
well as the documentation of the presence or absence of concurrent co-
morbidity and disability (Fig. 4).
The identification of frailty involves early treatment of the frailty
syndrome and close monitoring of patient capacities during and after
hospitalization in order to minimize disability. The most commonly
used interventions to treat frailty include, comorbidity optimization, ex-
ercise, protein-calorie supplementation, and the development of an in-
dividualized care and support plan based on a CGA [50,59]. Regarding
vitamin D3, it was not demonstrated to improve physical performance
in spite of the increase in serum 25OHD in older patients with HF [78].
These interventions can reverse frailty, but may have no effect on ad-
verse outcomes (hospitalizations, falls, or performance of activities of
daily living) in community-living older persons [79]. The presence of
significant functional decline or delirium in non-disabled older patients
with AHF should be considered as a high-risk situation that needs CGA.
Frailty should be determinedwith the currently used riskmodels for de-
cisionmaking. Regarding invasive procedures, the identification of frail-
ty, using frailty criteria [80–84] and performance tests (i.e. 5 m-gait
speed [85,86] and the timed-get up-and-go test [87]) has helped to pre-
dict short- and long-term adverse events in patients undergoingFig. 4.Management of older patients withtranscatheter aortic valve replacement [80,82], cardiac surgery [83], car-
diac resynchronization therapy [84] and post percutaneus coronary in-
terventions [81].
The presence of comorbidities and renal failure may make clinical
(i.e. chronic obstructive pulmonary disease (COPD)) [88] and biochem-
ical (i.e. renal failure) [89] diagnosis of AHF even more difficult in frail
older patients. Some comorbidities such as anemia, renal failure and
hyperglycaemia, may influence the short and long-term prognoses
[90–93]. The treatment of concurrent conditions in the frail older patients
with AHF should be optimized by balancing the risk–benefit relation (pri-
oritizations, interactions or contraindications) and making adjustments
according to creatinine clearance (MDRD-4). Polypharmacy should be
minimized because of the increased risk of adverse events and the conse-
quence of potentially reduced adherence. The application of evidence-
based medication review checklists (e.g. STOPP/START criteria) can be
helpful to reduce inappropriate medicine use [50]. Regarding heath
care, multi-provider or multi-settings should be avoided, or failing this,
they should bewell coordinated, with closemonitoring of activemorbid-
ities during both hospitalization and after discharge.
Disabled patients represent the highest risk scenario and require
more complex decision-making regarding treatment and care planning.
One out of three patients aged 85 years and older (one of six if
≥75 years) attending with AHF in the ED has a moderate or severe dis-
ability [5]. To facilitate the determination of frailty, we suggest
distinguishing between patients with middle or moderate and severe
disability. In moderate disability there may be a thin line dividingacute heart failure based on frailty.
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(Barthel Index 90–40 points). These decisions should be based on CGA
integrating risk scores, and frailty and disability components.
Palliative care, ethical constructs, advanced directives, and the ratio-
nalization of medications should be considered in patients with non-
acute severe disability. There is no evidence to guide end-of-life
decisions for older patients with HF. The usual medications such as
beta-blockers, diuretics, angiotensin-converting enzyme inhibitors, an-
giotensin receptor blockers, nitroglycerin and digoxin are recommend-
ed to maintain symptom relief and improve quality of life [94]. Other
treatments such as lipid-lowering medications and antiplatelet agents,
with the exception of aspirin, may never be indicated and anticoagu-
lants and antiarrhythmics may rarely be appropriate [95].
Regarding the transition of care, the discharge of all frail older pa-
tients with AHF should include a comprehensive care and support
plan. This should involve plans for optimization and maintenance,
self-care, escalation (what to look for and who to call), and emergency
responses that may include whether or not hospital care is appropri-
ate/desirable and what alternatives are in place [50]. All these aspects
are important in order to improve subjective and objective quality of
life in older patients with AHF [96].
6. Conclusions
In conclusion, 1) AHF is a multi-organ dysfunction syndrome. In ad-
dition to cardiac, renal, pulmonary, cerebral, and hepatic injuries, as
well as non-cardiac comorbidity, frailty and disability are independent
factors predictingmortality,morbidity, cognitive and functional decline,
and the risk of institutionalization in older patients with AHF; 2) frailty
(or state of vulnerability to stressors) is a treatable and potentially re-
versible syndromewhich increases the risk of disability and/or other ad-
verse health outcomes; 3) frailty identification is critical in older
patients with AHF in order to improve the stratification of prognosis
(disposition), the evaluation of the risk–benefits of invasive diagnostic
and therapeutic procedures and the development of older-person-cen-
tered and integrated care plans (person-centered coordinated care)
which have themain goal ofmaintaining or reversing potential declines
in physical and cognitive capacities; 4) though the best tool to deter-
mine frailty for use in research and clinical practice remains to be
established, we recommend the ISAR for the screening of frailty in ED,
and the Fried phenotype (i.e. Fried Scale) and Physical Performance
Test (i.e. SPPB) for the diagnosis of frailty during the hospitalization of
older patients with AHF; 5) CGA (or instruments derived from CGA) is
the instrument recommended for the evaluation and care of frail older
patients in clinical practice.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ijcard.2016.07.151.
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